AI model predicts which breast-cancer drugs work best

Researchers developed an AI-driven virtual cell model that predicts effective drugs for triple-negative breast cancer by analyzing tumor cell proteomics. The model was trained on extensive protein data from breast cancer cell lines treated with FDA-approved drugs, showing promise for personalized treatment.